TAMPA, FL / ACCESS Newswire / December 8, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRxâ"¢ into its patented blockchain-enabled smart contracts platform PharmacyChainâ"¢, today announced that it has begun the commercial launch of diabetes prescription drug Brenzavvy® to its network of 6,500 independent pharmacies (the "Wellgistics Pharmacy Network") th ...

TAMPA, FLORIDA / ACCESS Newswire / December 4, 2025 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader implementing EinsteinRxâ"¢ artificial intelligence prescription drug routing into blockchain-enabled smart contracts platform PharmacyChainâ"¢ to optimize the prescription medicines reimbursement and dispensing journey, today announced that it set a record date of December 19, 2025 for determining stockholders entitled to receive the Dream Bowl 2026 Meme Coin. ...

Group 1 - The company plans to distribute Dream Bowl 2026 Meme Coin to shareholders with a record date and distribution date expected in December 2025 [1] - Distribution of the Meme Coin is anticipated to occur in January 2026 [1] - Wellgistics Health, Inc. is involved in the DataVault AI Shareholder Distribution Plan and is sponsoring Dream Bowl 2026 [1] Group 2 - Wellgistics is a leader in health information technology, utilizing EinsteinRx™ artificial intelligence for prescription routing [1] - The company employs PharmacyChain™ blockchain-enabled smart contracts to enhance the tracking and dispensing of prescription drugs [1] - The technology aims to optimize insurance coverage from manufacturers to patients [1]

Core Insights - Wellgistics is positioned to lead in the Web 3.0 Health Information Data Transfer within the $634 billion prescription drug industry through an exclusive licensing agreement with Datavault AI [1][2][6] - The implementation of Wellgistics' EinsteinRx AI hub is expected to optimize automated prescription fulfillment for various stakeholders including manufacturers, pharmacies, and patients [1][4][6] - Datavault's intellectual property enables smart contracts that create a barrier to entry in the $4.9 trillion US healthcare market [1][2] Company Overview - Wellgistics Health, based in Tampa, Florida, specializes in optimizing medication delivery from manufacturers to patients, connecting over 6,500 pharmacies and 200 manufacturers [3][9] - The PharmacyChain initiative aims to digitize the tracking of prescription drugs, ensuring accurate delivery and recommendations for safe use [3][5] Technology and Innovation - The completion of the EinsteinRx AI hub integrates Wellgistics' IT and physical infrastructure, enhancing the efficiency of prescription fulfillment and reducing costs associated with pharmacy benefits managers (PBMs) [4][5][6] - Wellgistics aims to minimize or eliminate PBM rebates, thereby reducing administrative burdens for payers and improving the overall pharmaceutical distribution process [6][7] Market Potential - PwC estimates a $1 trillion opportunity to shift healthcare spending towards a digital-first, proactive, and personalized system [2] - The integration of smart contracts into Wellgistics' operations is expected to significantly improve cost efficiency in the prescription filling process, benefiting various stakeholders in the healthcare ecosystem [6][7]

Core Insights - Wellgistics Health has entered into a software as a service (SAAS) agreement with DataVault AI to develop a blockchain-enabled tracking and dispensing platform for the prescription drug market, named PharmacyChain™ [2][3] - The partnership aims to optimize Wellgistics' technology and infrastructure, with beta testing expected in the first half of 2026 [2][4] - The prescription drug market is valued at $639 billion, indicating significant potential for revenue generation through this collaboration [2][7] Company Overview - Wellgistics Health, Inc. is a leader in pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, connecting over 6,500 pharmacies and 200 manufacturers [8] - The company aims to restore access, transparency, and trust in U.S. healthcare through its integrated platform [8] Technology and Innovation - The PharmacyChain™ platform will utilize smart contracts to enhance the efficiency of prescription fulfillment, allowing pharmacies to securely receive and transfer data [4][6] - DataVault AI's technology will enable the creation of Digital Twins for pharmaceutical logistics and patient data, facilitating personalized healthcare recommendations based on individual health profiles [7] Market Impact - The collaboration is expected to attract significant interest from manufacturers, pharmacists, and insurers, enhancing the overall efficiency of the prescription fulfillment process [4] - The integration of diagnostic and biometric data is planned to further empower healthcare professionals and improve patient outcomes [6]

Market Performance - U.S. stocks experienced a positive trading session, with the Dow Jones index increasing by over 500 points, closing up 1.19% at 47,289.61, while NASDAQ rose 1.27% to 23,232.48, and S&P 500 gained 0.98% to 6,804.28 [1] - Communication services sector saw a rise of 1.2%, while energy stocks declined by 0.4% [1] Consumer Sentiment - The University of Michigan consumer sentiment index was revised down to 53.6 in October from a preliminary reading of 55 and compared to 55.1 in September [2][11] Commodity Prices - Oil prices increased by 0.7% to $62.19, while gold prices decreased by 0.1% to $4,143.10. Silver fell by 0.4% to $48.530, and copper dropped by 0.2% to $5.0985 [5] European Market Overview - European shares mostly rose, with the eurozone's STOXX 600 up 0.07%, Spain's IBEX 35 gaining 0.15%, London's FTSE 100 increasing by 0.32%, Germany's DAX 40 rising 0.14%, while France's CAC 40 fell by 0.30% [6] Asian Market Overview - Asian markets closed predominantly higher, with Japan's Nikkei 225 up 1.35%, Hong Kong's Hang Seng index gaining 0.74%, China's Shanghai Composite rising 0.71%, while India's BSE Sensex fell by 0.41% [7] Company-Specific Movements - Wellgistics Health, Inc. shares surged by 229% to $1.3501 following a non-binding letter of intent with Datavault AI Inc. for blockchain integration [9] - Genenta Science S.p.A. shares increased by 108% to $6.81 after announcing an expanded collaboration with ANEMOCYTE [9] - Inhibrx Biosciences, Inc. shares rose by 74% to $49.26 after reporting positive results for Ozekibart in chondrosarcoma treatment [9] - Deckers Outdoor Corporation shares fell by 13% to $89.00 after reporting second-quarter results that missed analyst estimates [9] - MultiSensor AI Holdings, Inc. shares dropped by 46% to $0.7340 due to a $14 million private placement announcement [9] - MaxLinear, Inc. shares decreased by 13% to $15.31 following third-quarter results [9] Economic Indicators - The S&P Global services PMI increased to 55.2 in October from 54.2 in the previous month, exceeding market expectations of 53.5 [11] - The S&P Global manufacturing PMI rose to 52.2 in October from 52.0, also surpassing estimates of 52.0 [11] - The S&P Global composite PMI jumped to 54.8 in October from 53.9 in September [11] - Year-ahead inflation expectations in the U.S. decreased to 4.6% in October from 4.7% in September [11]

Market Performance - U.S. stocks experienced a positive trading session, with the Dow Jones index increasing by more than 500 points, closing up 1.19% at 47,289.61. The NASDAQ rose 1.27% to 23,232.48, and the S&P 500 gained 0.98% to 6,804.28 [1] - Communication services sector saw a rise of 1.2%, while energy stocks declined by 0.4% [1] Economic Indicators - The University of Michigan consumer sentiment index was revised down to 53.6 in October from a preliminary reading of 55 and compared to 55.1 in September [2][11] - The S&P Global services PMI increased to 55.2 in October from 54.2 in the previous month, exceeding market expectations of 53.5 [11] - The S&P Global manufacturing PMI rose to 52.2 in October from 52.0, also surpassing estimates of 52.0 [11] - The S&P Global composite PMI jumped to 54.8 in October from 53.9 in September [11] - Year-ahead inflation expectations in the U.S. decreased to 4.6% in October from 4.7% in September [11] Commodity Prices - Oil prices increased by 0.7% to $62.19, while gold prices decreased by 0.1% to $4,143.10. Silver fell by 0.4% to $48.530, and copper dropped by 0.2% to $5.0985 [5] International Markets - European shares were mostly higher, with the eurozone's STOXX 600 rising by 0.07%. Spain's IBEX 35 gained 0.15%, London's FTSE 100 rose by 0.32%, Germany's DAX 40 increased by 0.14%, while France's CAC 40 fell by 0.30% [6] - Asian markets closed mostly higher, with Japan's Nikkei 225 gaining 1.35%, Hong Kong's Hang Seng index up by 0.74%, and China's Shanghai Composite rising by 0.71%. India's BSE Sensex, however, fell by 0.41% [7] Company News - Wellgistics Health, Inc. shares surged by 229% to $1.3501 after signing a non-binding letter of intent with Datavault AI Inc. to integrate blockchain technology [9] - Genenta Science S.p.A. shares increased by 108% to $6.81 following an expanded collaboration with ANEMOCYTE [9] - Inhibrx Biosciences, Inc. shares rose by 74% to $49.26 after positive trial results for Ozekibart in chondrosarcoma [9] - Deckers Outdoor Corporation shares fell by 13% to $89.00 after reporting second-quarter results that missed revenue estimates [9] - MultiSensor AI Holdings, Inc. shares dropped by 46% to $0.7340 due to a $14 million private placement announcement [9] - MaxLinear, Inc. shares decreased by 13% to $15.31 following third-quarter results [9]

Market Overview - U.S. stocks experienced an upward trend, with the Nasdaq Composite increasing by 1% on Friday [1] - The Dow Jones rose by 0.80% to 47,108.01, while the S&P 500 gained 0.83% to 6,794.12 [1] - Information technology shares saw a notable increase of 1.3%, while materials stocks declined by 0.3% [1] Company Performance - Procter & Gamble Co. reported better-than-expected earnings per share (EPS) of $1.99 for Q3, a 3% increase year-over-year, surpassing the analyst consensus of $1.90 [2] - The company's quarterly sales reached $22.386 billion, exceeding the expected $22.175 billion [2] - Procter & Gamble raised its fiscal 2026 adjusted EPS guidance to a range of $6.83-$7.10, compared to the previous range of $6.83-$7.09 and above the analyst estimate of $6.97 [3] - The sales outlook for fiscal 2026 was adjusted to $85.127 billion-$88.498 billion, slightly up from the previous range and below the expected $86.919 billion [3] Stock Movements - Wellgistics Health, Inc. shares surged by 183% to $1.17 following a non-binding letter of intent with Datavault AI Inc. [8] - Genenta Science S.p.A. saw its shares increase by 145% to $7.93 due to an expanded collaboration with ANEMOCYTE [8] - Neuphoria Therapeutics Inc. shares rose by 89% to $7.61 after a significant share purchase by a shareholder [8] - Conversely, Picard Medical, Inc. shares dropped by 72% to $3.67, and MultiSensor AI Holdings, Inc. shares fell by 46% to $0.7304 after announcing a private placement [8] Economic Indicators - The S&P Global services PMI increased to 55.2 in October from 54.2 in September, surpassing market expectations of 53.5 [11] - The S&P Global manufacturing PMI rose to 52.2 in October from 52.0, exceeding estimates of 52.0 [11] - The S&P Global composite PMI jumped to 54.8 in October from 53.9 in September [11]

Group 1: Intel Corporation - Intel Corporation reported third-quarter revenue of $13.65 billion, exceeding analyst estimates of $13.14 billion [1] - The company achieved adjusted earnings of 23 cents per share, surpassing estimates of one cent per share [1] - Following the positive financial results, Intel shares increased by 8.4% to $41.37 in pre-market trading [1] Group 2: Other Stocks in Pre-Market Trading - Qualigen Therapeutics, Inc. gained 106.7% to $7.30 after announcing a strategic partnership with BitGo [5] - Wellgistics Health, Inc. surged 74.4% to $0.7036 following a non-binding letter of intent with Datavault AI Inc. [5] - Inhibrx Biosciences, Inc. rose 54.6% to $43.85 after reporting positive results for Ozekibart in chondrosarcoma [5] - Vivakor, Inc. increased by 37.2% to $0.3570 after announcing a $40 million credit facility [5] - MidWestOne Financial Group, Inc. surged 27.7% to $36.24 following an acquisition announcement by Nicolet Bankshares [5] - Ford Motor Company rose 2.8% to $12.66 after reporting third-quarter adjusted EPS and sales above estimates [5] Group 3: Declining Stocks in Pre-Market Trading - Picard Medical, Inc. tumbled 65.3% to $4.61 in pre-market trading [5] - Scienture Holdings, Inc. declined 30.3% to $1.81 after a significant price increase the previous day [5] - MultiSensor AI Holdings, Inc. fell 27.1% to $0.9840 after a prior surge [5] - American Rebel Holdings, Inc. dipped 22% to $2.94 following a substantial increase [5] - Aptera Motors Corp. fell 19.7% to $8.71 after a notable climb [5] - INNEOVA Holdings Limited decreased by 8.7% to $0.9311 after a previous jump due to a contract award [7] - Newmont Corporation fell 5.8% to $83.69 following its third-quarter results [7]

Core Insights - The partnership between DataVault AI and Wellgistics aims to digitize the U.S. prescription drug market, valued at $634.32 billion, through blockchain-enabled smart contracts to enhance efficiency and transparency in drug distribution [1][2][3] Company Overview - DataVault AI specializes in AI-driven data experiences and monetization, leveraging patented technologies to innovate across various industries, including healthcare [4][5] - Wellgistics Health focuses on improving medication delivery from manufacturers to patients, utilizing an integrated platform that connects over 6,500 pharmacies and 200 manufacturers [6] Strategic Partnership - The collaboration will implement the PharmacyChain™ platform, which seeks to ensure accurate tracking of prescription drugs from the point of prescription to fulfillment, enhancing patient safety and compliance [1][2] - The companies plan to establish a revenue-sharing model based on fees from pharmacies utilizing the PharmacyChain technology [1][3] Technological Innovations - Wellgistics has introduced HubRx AI, an AI engine designed to optimize pharmacy operations, reduce costs, and improve patient outcomes while maintaining compliance with healthcare regulations [2][3] - The integration of various technological tools, including Einstein Rx AI and Wellgistics Hub, aims to enhance the overall efficiency of prescription drug services [2] Market Impact - The implementation of blockchain technology is expected to minimize administrative burdens, improve patient access to medications, and enhance the overall prescription ecosystem [3] - The partnership is positioned to create a scalable opportunity that aligns financial incentives with improved patient outcomes across the healthcare spectrum [2][3]